Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Filamon LTD
AstraZeneca
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
On Target Laboratories, LLC
PMV Pharmaceuticals, Inc
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Whitehawk Therapeutics, Inc.
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
ViroMissile, Inc.
Sichuan Enray Pharmaceutical Sciences Company
Carevive Systems, Inc.
A2 Biotherapeutics Inc.
Tizona Therapeutics, Inc
Essen Biotech